TERT and ovarian cancer: We previously observed that GSK3 inhibition causes widespread TERT promoter remodelling and that GSK3 inhibited ovarian cancer cells show long-term unstable telomerase suppression, correlating with altered protein expression and oscillation of several TERT regulatory factors, particularly c-Jun [4].